Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
How to preserve muscle mass on weight-loss drugs like Wegovy
There is some debate as to whether GLP-1 agonist drugs like Wegovy can lead to unhealthy muscle mass loss in addition to general weight loss. Is this a real concern, and if so, how can a person maintain their muscle mass on GLP-1 drugs?
Weight loss, diabetes drugs can also protect kidneys: Study
The popular glucagon-like peptide-1 (GLP-1) receptor agonists known to help in weight loss as well as manage blood sugar can also protect the kidneys, regardless of diabetes status, finds a study led by an Indian-origin researcher.
Weight-loss drugs can improve kidney health, study finds
Weight-loss drugs can reduce the risk of worsening kidney function, kidney failure and dying from kidney disease by a fifth, according to a study. Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of medications that help people shed the pounds,
Diabetes drug shows promise in protecting kidneys
Researchers evaluated the effects of SGLT2 inhibitors in protecting the kidneys, showing that the drugs might help improve oxygenation in these organs.
Popular diabetes and obesity drugs also protect kidneys, study suggests
Popular diabetes and obesity drugs also protect kidneys, study suggests - The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, researchers found.
News Medical on MSN
4h
GLP-1 receptor agonists reduce kidney failure risk and cardiovascular events
Researchers evaluate the effects of glucagon-like peptide-1 receptor agonists on kidney and cardiovascular outcomes.
1d
on MSN
Popular diabetes and obesity drugs also protect kidneys, study shows
The biggest and most comprehensive analysis of glucagon-like peptide-1 (GLP-1) receptor agonists on kidney and cardiovascular ...
HealthDay on MSN
5d
Glucagon-Like Peptide-1 Receptor Agonists May Reduce Alcohol Consumption
Glucagon-like peptide-1 receptor agonist (GLP-1 RA) use may reduce alcohol consumption and improve outcomes in some ...
CMAJ
2d
Glucagon-like peptide-1 receptor agonists for treating chronic kidney disease in patients with type 2 diabetes
In a randomized controlled trial of people with type 2 diabetes, albuminuria, and estimated glomerular filtration rate (eGFR) ...
Newsday
1d
Wegovy, Mounjaro: Suffolk County issues new guidelines for access to costly weight-loss drugs
Those on the medications, known as GLP-1s or
glucagon-like
peptide-1
, will additionally weigh in four times a month on ...
Health on MSN
29d
Medications That Could Interact With GLP-1s
Glucagon-like
peptide-1
(GLP-1) agonists are a class of medications primarily used to treat type 2 diabetes. GLP-1s work ...
Daily
8d
Glucagon-like peptide-1 receptor Agonists can effectively control Alcohol Use Disorder, finds study
A recent study found that glucagon-like peptide-1 receptor (GLP-1) agonists like semaglutide and liraglutide are effective in ...
Too Old to Operate
2d
GLP-1 Receptor Agonists and Hepatocellular Carcinoma Risk in Diabetes
The following is a summary of “Risk of Hepatocellular Carcinoma with Glucagon-like Peptide-1 receptor agonist treatment in patients: a systematic review and meta-analysis,” published in the November ...
News Medical on MSN
7d
Impact of glucagon-like peptide-1 receptor agonists on alcohol consumption
The impact of GLP-1 RAs on alcohol use is explored, showing potential benefits in reducing intake and cravings, but with ...
5d
7 Ways To Naturally Optimize Your GLP-1 Response & Lose Weight Fast
A registered dietitian shares the best diet and exercise tips to help optimize your GLP-1 response for faster weight loss.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback